Methamphetamine and the Synthetic Cathinone 3,4-Methylenedioxypyrovalerone (MDPV) Produce Persistent Effects on

Erin K Nagy1, Paula F Overby1, Jonna M Leyrer-Jackson2

  • 1Department of Psychology, Behavioral Neuroscience and Comparative Psychology Area, Arizona State University, Tempe, AZ 85287, USA.

Brain Sciences
|May 25, 2024
PubMed

Insights

Repeated methamphetamine (METH) and MDPV use alters brain cell structure and neuroinflammation, with changes persisting after abstinence. These psychostimulants impact dendritic spines and microglial cells in addiction-related brain regions.

Area of Science:

  • Neuroscience
  • Neuropharmacology
  • Cellular Biology

Background:

  • Psychostimulants can alter brain cell structure and neuroimmune responses.
  • Few studies have examined the long-term effects of high voluntary psychostimulant intake and abstinence on brain changes.

Purpose of the Study:

  • To investigate the persistent effects of binge-like methamphetamine (METH) and 3,4-methylenedioxypyrovalerone (MDPV) self-administration on cell density, morphology, and cytokine levels in the prefrontal cortex (PFC) and dorsal striatum (DStr).
  • To compare these effects between sexes following a 21-day abstinence period.

Main Methods:

  • Rats (male and female) underwent repeated binge-like self-administration of METH or MDPV (96 h/week for 3 weeks).
  • Cell density, morphology, and cytokine levels in the PFC and DStr were analyzed after 21 days of abstinence.
  • Control animals received saline.

Main Results:

  • No changes in astrocyte or neuron density were observed.
  • Decreased dendritic spine densities were found in PFC pyramidal and DStr medium spiny neurons.
  • METH self-administration led to decreased microglial cell density in the PFC, with evidence of apoptosis and altered morphology indicative of inflammation.
  • Elevated levels of interleukins and chemokines were detected in the PFC and DStr of METH-treated animals, showing region- and sex-dependent effects.

Conclusions:

  • Voluntary binge-like intake of METH or MDPV induces persistent cellular changes in addiction-related brain regions.
  • METH self-administration triggers divergent neuroimmune responses, including microglial alterations and elevated cytokine levels, that persist beyond acute abstinence.

Related Concept Videos

Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
Stimulants01:29

Stimulants

Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...